Goal
Protect living organisms from lethal radiation exposure
Problem
Radiation damage from nuclear accidents, dirty bombs, and high-dose radiotherapy
Concept Summary
A drug composed of bacterial flagellin protein is administered to mammals to suppress radiation-induced apoptosis and promote cellular recovery, thereby increasing survival after otherwise lethal radiation doses.
Principles
- Protein-mediated suppression of apoptosis
- Activation of innate immune receptor TLR5
- Enhancement of DNA repair pathways
Scientific Domains
Materials
- Bacterial flagellin protein
Mechanisms of Action
- Flagellin binds TLR5, modulating signaling that reduces radiation-induced cell suicide
- Induction of protective gene expression that aids DNA damage repair
Applications
- Emergency protection against nuclear or dirty-bomb radiation
- Adjunct to cancer radiotherapy to allow higher dose delivery
Claimed Performance
In a study of 650 monkeys exposed to Chernobyl-level radiation, 70% of untreated animals died while almost all of those receiving the flagellin drug survived with no side effects; a human safety test reported no adverse effects.
Experimental Evidence
The article cites a test on 650 monkeys where the medication prevented death in the majority of subjects, and a separate test on humans not exposed to radiation showed no side effects.
Limitations
- No peer-reviewed clinical trial data
- Potential immune reactions to bacterial protein
- Manufacturing and formulation of pure flagellin
Red Flags
- Claims based on a single animal study and unpublished human safety test
- Lack of independent replication or regulatory approval at time of reporting
